Monday, March 8th, 2021
U.S. Manufacturer has ramped up production of Viral Transport Media to support COVID testing and tracing in the U.S. and Canada
MEDFORD, Ore., March 8, 2021 (Newswire.com) - Biomed Diagnostics, a medical device innovator and manufacturer, is pleased to announce the commercial availability of its viral transport medium (VTM) to support testing in the US and Canada for the virus causing COVID-19 disease.
Biomed has significantly increased production volume of two transport media devices: VTM-C19™ and Saline Solution (.85%)™. Both formulations have been validated for the safe transport and preservation of specimens from patients being tested for SARS-CoV-2 (COVID-19), influenza A, and RSV.